Neurofit Participates in Alzheimer's Association International Conference... Showcases Brain Imaging Analysis AI Platform 'SegPlus'

[Asia Economy Reporter Hyunseok Yoo] Neurofit, an AI solution company specializing in brain disease, announced on the 12th that it showcased its brain imaging analysis AI platform, 'Neurophet SegPlus (hereafter SegPlus),' at the Alzheimer’s Association International Conference (AAIC 2021).

The Alzheimer’s Association International Conference is an annual academic conference where leading researchers in the field of dementia science present and discuss the latest research results and theories. This year, it was held both in Denver, USA, and virtually, with over 10,000 participants and more than 3,000 presentations.

‘SegPlus,’ developed by Neurofit, is a cloud-based AI analysis platform for brain imaging analysis. Existing brain imaging analysis programs used in neuroscience research have drawbacks such as difficult installation and analysis times exceeding a day. ‘SegPlus’ offers a fully automated process through an advanced AI engine, enabling brain imaging analysis to be completed in just 3 minutes.

Additionally, ‘SegPlus’ does not require separate program downloads or installations, making it easily accessible to users. Analyzing images like MRI typically requires a high-level hardware analysis environment, but ‘SegPlus’ can be used easily by anyone in a web environment with internet access, free of charge for a certain period.

‘SegPlus’ provides a brain volume analysis type that subdivides and quantifies the brain into 98 regions. Neurofit plans to further advance ‘SegPlus’ by adding various brain imaging analysis types for research purposes, including white matter hyperintensities (WMH), brain tumors, stroke, and cerebral microbleeds.

Bin Jungil, CEO of Neurofit, said, “We are pleased to present ‘SegPlus’ at the Alzheimer’s Association International Conference,” and added, “We hope many researchers will conduct brain imaging analysis using ‘SegPlus’ to aid their research and paper presentations.”

He continued, “Since the company’s mission is to contribute to the advancement of neuroscience and overcoming brain diseases, we will continue to release excellent solutions to support neuroscience researchers’ studies.”

This content was produced with the assistance of AI translation services.